Severe imported Plasmodium falciparum malaria in children: characteristics and useful factors in the risk

Agnese Comelli1, María Espiau Guarner2, Lina Rachele Tomasoni1

  • 1University Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili, Brescia, Italy.

Insights

A new scoring model using age, white blood cells (WBC), and C-reactive protein can identify children at high risk for severe imported malaria in non-endemic areas.

Area of Science:

  • Pediatric Infectious Diseases
  • Tropical Medicine
  • Clinical Epidemiology

Background:

  • Severe imported pediatric malaria poses a significant challenge in non-endemic regions.
  • Accurate risk stratification of pediatric severe malaria cases is crucial for timely intervention.

Purpose of the Study:

  • To identify key features of severe pediatric malaria cases.
  • To develop a predictive model for stratifying patient risk upon presentation.

Main Methods:

  • Retrospective cross-sectional study of imported P. falciparum malaria in children (≤14 years) from 2008-2019.
  • Analysis of adverse outcomes including mortality, PICU admission, and blood transfusion.
  • Development and evaluation of a predictive model using clinical and laboratory parameters.

Main Results:

  • 30.9% of pediatric malaria cases were classified as severe.
  • Predictors for severe malaria included young age, low hemoglobin, elevated white blood cells (WBC), and high C-reactive protein.
  • A model incorporating age, WBC, and C-reactive protein demonstrated high specificity (92.3%) for identifying non-severe cases.

Conclusions:

  • A simple scoring system based on age, WBC, and C-reactive protein can effectively identify children at higher risk of adverse outcomes.
  • This score is easily applicable in emergency room settings for rapid risk assessment.
  • The model aids in early detection and management of severe pediatric malaria.
Abstract

Related Concept Videos

Diversity of Protists II01:27

Diversity of Protists II

Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
312
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
27
Symbiosis00:58

Symbiosis

Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
34.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
23
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
23
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
32